ILLUMINA INC (ILMN) Stock Price, Quote, News and Summary
NASDAQ:ILMN - Nasdaq - US4523271090 - Common Stock
ILMN Quote and Key Statistics
ILLUMINA INC
NASDAQ:ILMN (1/21/2025, 6:12:31 PM)
After market: 141.9 +0.59 (+0.42%)141.31
+4.64 (+3.4%)
ILMN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.34% | ||
| ROE | -74.54% | ||
| Debt/Equity | 0.94 |
ILMN Performance and Technical Analysis
ILMN Ownership and Analysts
ILMN Latest News and Analysis
First Week of ILMN September 19th Options Trading
Illumina CEO Thaysen on Nvidia Partnership, Genomics, M&A
Illumina CEO Jacob Thaysen discusses the outlook for genomics and the company's partnership with Nvidia. He speaks with Katherine Greifeld at the JPMorgan Health-Care Conference in San Francisco. (Source: Bloomberg)
Illumina Raises Q4 Revenue Outlook To $1.10 Billion, Exceeding Street Expectations; Sees Solid Margins
Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.
Illumina and NVIDIA collaborate to decode biology and propel precision health
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance...
Nvidia Unveils Tie-Ups With Illumina, Mayo Clinic in Health Push
Nvidia Corp. announced tie-ups with Illumina Inc., the Mayo Clinic and other health-care organizations as part of its push to encourage the adoption of artificial intelligence by that industry.
About ILMN
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122 US
CEO: Francis A. deSouza
Employees: 10615
Company Website: https://www.illumina.com
Investor Relations: https://investor.illumina.com
Phone: 18582024500
ILMN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.74 | 219.20B | ||
| DHR | DANAHER CORP | 32.81 | 176.32B | ||
| A | AGILENT TECHNOLOGIES INC | 28.84 | 43.51B | ||
| IQV | IQVIA HOLDINGS INC | 18.94 | 37.33B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 34.72 | 27.95B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 50.99 | 24.96B | ||
| WAT | WATERS CORP | 36.33 | 24.57B | ||
| ICLR | ICON PLC | 14.62 | 16.93B | ||
| RVTY | REVVITY INC | 26.21 | 15.08B | ||
| AVTR | AVANTOR INC | 22.21 | 14.82B | ||
| TECH | BIO-TECHNE CORP | 43.99 | 12.51B | ||
| MEDP | MEDPACE HOLDINGS INC | 30.43 | 10.80B |